The Peptide NewsroomPeptide research, industry and supply-chain headlines

Martha Stewart's Elm Launches a $45 Peptide Lip Serum, But Its Study Is a Perception Test

Topic card: skin-beauty

Elm Biosciences, the skincare company co-founded by Martha Stewart and board-certified dermatologist Dr. Dhaval Bhanusali, is launching Elemental Lip Serum on September 22 at $45, in four shades: Blush, Petal, Mocha, and Clear.

The product is described as a balm-oil hybrid built around peptides, antioxidants, shea butter, squalane, and what the brand calls a deep hydration complex. Peptides are short chains of amino acids used in cosmetic formulas as conditioning and signaling ingredients, and their inclusion here is the reason a lip balm lands on a peptide news desk rather than a beauty column.

The pitch is lip care as skin care

Elm's argument is that lips are one of the most overlooked parts of a beauty routine and deserve the same treatment logic as facial skin. That framing is doing real work commercially: it moves a tinted balm out of the makeup aisle, where $45 is a hard sell, and into treatment, where it is unremarkable.

The serum is positioned to address visible signs of lip aging while delivering hydration, comfort, and a sheer tint. In other words, wearable color with treatment claims attached, which is the most crowded corner of the category right now.

What the study actually was

Elm Biosciences points to a dermatologist-supervised perception study involving 54 women who used the product for seven days. A perception study asks users what they noticed, which is a different kind of evidence from an instrumented measure of hydration or lip texture, and seven days is a short window for anything described as long-term care.

No outcome figure from that study appears in the coverage, and the brand's own framing concedes that individual results can vary. For a formula sold on visible signs of lip aging, the absence of a published result is the most informative detail available.

The dermatologist network

The company says its product development is informed by a network of more than 350 dermatologists, scientists, and researchers. That is a credentialing claim, not a data claim, and the two get conflated often enough in this category to be worth separating.

Bottom line

What Elm has launched is a peptide-containing tinted lip treatment at $45 with a seven-day user-perception study behind it. Whether the formula does anything measurable to lip skin over months rather than a week is a question nobody has published an answer to yet.

Source: RSS.app — Peptides bundle. Read the original.

Filed under: skin-beauty

Comments (0)

Discussion happens on Reddit.
Questions and corrections go to r/PeptideNewsroom.

Go to r/PeptideNewsroom

Corrections are the most useful thing you can post. Comments touching dosing, sourcing or links are held for a moderator first.

More from The Peptide Newsroom

NAD+ Sells as Anti-Aging Science, But the Published Evidence Is Still Thin

NAD+ is sold as both a clinic infusion and an oral precursor, but none of the current coverage names a human trial, a dose or an outcome figure. A New York medical examiner has ruled one infusion death a homicide, while dermatologists are still publicly asking whether the category is hope or hype.

Allergan Aesthetics Reports Skin Gains in GLP-1 Patients, But the Studies Are Tiny

Allergan Aesthetics presented two single-center studies of skincare regimens in people taking weight loss medications, reporting improvements in selected skin quality measures. The combined enrollment across both studies was 20 participants, and the company says larger research is needed.

Semaglutide Extended Lifespan in Older Female Mice, But the Control Group Complicates It

A preclinical study reports that semaglutide started late in life was associated with a 12% longer median lifespan in female mice, plus better memory, endurance and glucose control. The catch is a control group that died earlier than this strain usually does, which leaves an alternative explanation open.